Back
Armata Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45
ARMP
Armata Pharmaceuticals
Last Price:
$1.97
Seasonality Move:
4.45%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and ARMP is experiencing slight selling pressure.
Armata Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.98 | Sell |
| 20-day SMA: | 1.74 | Buy |
| 50-day SMA: | 1.51 | Buy |
| 200-day SMA: | 2.02 | Sell |
| 8-day EMA: | 1.96 | Sell |
| 20-day EMA: | 1.81 | Buy |
| 50-day EMA: | 1.69 | Buy |
| 200-day EMA: | 2 | Sell |
Armata Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 56.1 | Buy |
| Chaikin Money Flow: | -6859 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.35 - 2.03) | Buy |
| Bollinger Bands (100): | (1.41 - 2.13) | Buy |
Armata Pharmaceuticals Technical Analysis
| May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Armata Pharmaceuticals Stock
Is Armata Pharmaceuticals Stock a Buy?
-
Armata Pharmaceuticals share price is 1.93 while ARMP 8-day simple moving average is 1.98, which is a Sell signal.
-
The stock price of ARMP is 1.93 while Armata Pharmaceuticals 20-day SMA is 1.74, which makes it a Buy.
-
Armata Pharmaceuticals 50-day simple moving average is 1.51 while ARMP share price is 1.93, making it a Buy technically.
-
ARMP stock price is 1.93 and Armata Pharmaceuticals 200-day simple moving average is 2.02, creating a Sell signal.
ARMP Technical Analysis vs Fundamental Analysis
Sell
45
Armata Pharmaceuticals (ARMP)
is a Sell
Is Armata Pharmaceuticals a Buy or a Sell?
-
Armata Pharmaceuticals stock is rated a SellThe current Armata Pharmaceuticals [ARMP] share price is $1.93. The Score for ARMP is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Armata Pharmaceuticals Stock Info
Market Cap:
69.9M
Price in USD:
1.93
Share Volume:
16.8K
Armata Pharmaceuticals 52-Week Range
52-Week High:
3.42
52-Week Low:
0.90
Sell
45
Armata Pharmaceuticals (ARMP)
is a Sell
Armata Pharmaceuticals Share Price Forecast
-
What is the Armata Pharmaceuticals stock price today?The Armata Pharmaceuticals stock price is 1.93 USD today.
-
Will ARMP stock go up or go down?Armata Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Armata Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Armata Pharmaceuticals is overvalued.
Is Armata Pharmaceuticals Stock a Buy?
-
Armata Pharmaceuticals share price is 1.93 while ARMP 8-day exponential moving average is 1.96, which is a Sell signal.
-
The stock price of ARMP is 1.93 while Armata Pharmaceuticals 20-day EMA is 1.81, which makes it a Buy.
-
Armata Pharmaceuticals 50-day exponential moving average is 1.69 while ARMP share price is 1.93, making it a Buy technically.
-
ARMP stock price is 1.93 and Armata Pharmaceuticals 200-day simple moving average is 2.00, creating a Sell signal.
Fundamental Analysis of Armata Pharmaceuticals
Is Armata Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.99 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Armata Pharmaceuticals
Should I short Armata Pharmaceuticals stock?
-
ARMP Moving Average Covergence Divergence (MACD) indicator is 0.15, suggesting Armata Pharmaceuticals is a Buy
-
Armata Pharmaceuticals Relative Strength Index (RSI) is 56.1, which suggest Armata Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Armata Pharmaceuticals is (1.35 - 2.03), which suggest Armata Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Armata Pharmaceuticals is (1.41 - 2.13), which suggest Armata Pharmaceuticals is a Buy
* Armata Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.